Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 6, 2025
Date Accepted: Jan 20, 2026

The final, peer-reviewed published version of this preprint can be found here:

Developing and Evaluating a WeChat-Based Applet Fluid Intake Reminder on Enhancing Fluid Adherence in Postoperative Patients With Urinary Calculi: Protocol for a Randomized Controlled Trial

Zhou X, WANG T, Zhang L, Chen Q

Developing and Evaluating a WeChat-Based Applet Fluid Intake Reminder on Enhancing Fluid Adherence in Postoperative Patients With Urinary Calculi: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e80214

DOI: 10.2196/80214

PMID: 41712953

PMCID: 12919965

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Developing and evaluating a WeChat-based digital therapeutic intervention to enhance fluid adherence in postoperative patients with urinary calculi: study protocol of an RCT

  • Xue Zhou; 
  • Tongyao WANG; 
  • Linan Zhang; 
  • Qian Chen

ABSTRACT

Background:

Urinary calculi, affecting 1-13% globally, pose a significant health burden due to high recurrence rates (up to 50% within 10 years) and substantial healthcare costs. Adequate fluid intake is a cornerstone of prevention, yet its adherence remains poor due to forgetfulness, lifestyle barriers, and limited patient education. Existing mobile health (mHealth) interventions for urinary calculi prevention often lack medical oversight and clinical validation. WeChat-based digital therapeutic (DTx) intervention may have a positive effect on fluid adherence in this patient group.

Objective:

Our objective is to develop a WeChat applet to improve hydration behaviour and reduce stone recurrence among postoperative patients with urinary calculi.

Methods:

This is an open-label, two-arm, parallel-group randomized controlled trial. 148 participants from China’s tertiary hospital will be recruited and randomly allocated in a ratio of 1:1 to the intervention/control group. Eligible participants will receive either standard care or a WeChat-based digital therapeutic intervention after surgery for urolithiasis. Fluid adherence will be measured by 24-hour fluid intake and urine volume; secondary outcomes will be measured by the Wisconsin Stone Quality of Life Questionnaire (WSQOL), Patient Health Questionnaire-9 (PHQ-9), eHealth Literacy Scale (eHEALS), physical activity, and recurrence rate. Outcomes are measured before intervention (M0) and after a one-month (M1) and three-month (M2) follow-up period, with within- and between-group comparisons. Intention-to-treat analysis, t-tests, and repeated measures ANOVA will be used to compare outcomes; statistical significance is set at a p < 0.05 significance threshold. Recruitment commenced on March 1, 2025.

Results:

This research will assess whether a nurse-led, evidence-based digital therapeutic intervention delivered via WeChat is effective in overcoming fluid adherence barriers in postoperative patients with urinary calculi.

Conclusions:

It is expected to increase daily fluid intake and urine output, reduce recurrence rates, and improve quality of life while generating empirical evidence for DTx application in urology care. The study seeks to optimize postoperative management for urinary calculi within clinical settings. Clinical Trial: ClinicalTrials.gov: NCT06990672 Registered 24 May 2025—retrospectively registered


 Citation

Please cite as:

Zhou X, WANG T, Zhang L, Chen Q

Developing and Evaluating a WeChat-Based Applet Fluid Intake Reminder on Enhancing Fluid Adherence in Postoperative Patients With Urinary Calculi: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e80214

DOI: 10.2196/80214

PMID: 41712953

PMCID: 12919965

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.